{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:44:47Z","timestamp":1789515887289,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018854","name":"Sirtex Medical Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jvir.2023.11.026","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T17:02:25Z","timestamp":1705683745000},"page":"689-698.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Treated by Yttrium-90 Resin Microsphere Radioembolization: A Retrospective Analysis Using Technetium-99m Macroaggregated Albumin SPECT\/CT and Planning Software"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2376-1799","authenticated-orcid":false,"given":"Patrick W.","family":"Doyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-2863","authenticated-orcid":false,"given":"C. Spencer","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared V.","family":"Grice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey W.","family":"McGonigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-6239","authenticated-orcid":false,"given":"Jennifer C.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-2883","authenticated-orcid":false,"given":"Daniel B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2023.11.026_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2023.11.026_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.annonc.2019.12.001","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced\/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO","volume":"31","author":"Chen","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2023.11.026_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2023.11.026_bib4","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1007\/s00259-022-05776-y","article-title":"Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors","volume":"49","author":"Montazeri","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.11.026_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jvir.2021.03.535","article-title":"Multicenter evaluation of survival and toxicities of hepatocellular carcinoma following radioembolization: analysis of the RESiN registry","volume":"32","author":"Frantz","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.11.026_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.11.026_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.semnuclmed.2019.01.005","article-title":"Dosimetry of Y-90 microspheres utilizing Tc-99m SPECT and Y-90 PET","volume":"49","author":"Tafti","year":"2019","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2023.11.026_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2023.11.026_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s00330-020-07231-8","article-title":"Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres","volume":"31","author":"Sarwar","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvir.2023.11.026_bib12","article-title":"Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: results from the prospective CIRT study","volume":"5","author":"Kolligs","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jvir.2023.11.026_bib13","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.11.026_bib14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","article-title":"Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres","volume":"34","author":"Villalobos","year":"2023","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.11.026_bib15","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1097\/MD.0000000000000945","article-title":"PET\/CT-based dosimetry in 90Y-microsphere selective internal radiation therapy: single cohort comparison with pretreatment planning on (99m)Tc-MAA imaging and correlation with treatment efficacy","volume":"94","author":"Song","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jvir.2023.11.026_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2967\/jnumed.116.173104","article-title":"Partition model-based 99mTc-MAA SPECT\/CT predictive dosimetry compared with 90Y TOF PET\/CT posttreatment dosimetry in radioembolization of hepatocellular carcinoma: a quantitative agreement comparison","volume":"57","author":"Gnesin","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2967\/jnumed.112.117614","article-title":"99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization","volume":"54","author":"Wondergem","year":"2013","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0041-1735569","article-title":"Post yttrium-90 imaging","volume":"38","author":"Rice","year":"2021","journal-title":"Semin Interv Radiol"},{"key":"10.1016\/j.jvir.2023.11.026_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246848","article-title":"Evaluation of qualitative and quantitative data of Y-90 imaging in SPECT\/CT and PET\/CT phantom studies","volume":"16","author":"Kubik","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2023.11.026_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00259-011-1940-8","article-title":"The significance of bremsstrahlung SPECT\/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects","volume":"39","author":"Ahmadzadehfar","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.11.026_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2967\/jnumed.110.080986","article-title":"Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept","volume":"52","author":"Gates","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/MNM.0000000000000872","article-title":"Hepatic selective internal radiation therapy: how well does pretreatment 99mTc-macroaggregated albumin activity distribution and quantification agree with post-therapy bremsstrahlung imaging?","volume":"39","author":"Dickinson","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jvir.2023.11.026_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00259-023-06111-9","article-title":"Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study","volume":"50","author":"Kokabi","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.11.026_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jvir.2023.11.026_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jvir.2023.11.026_bib26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2010.262","article-title":"Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma","volume":"303","author":"Riaz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jvir.2023.11.026_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2023.11.026_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2016.07.021","article-title":"Selective internal radiation therapy with yttrium-90 glass microspheres: biases and uncertainties in absorbed dose calculations between clinical dosimetry models","volume":"96","author":"Mikell","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2023.11.026_bib29","series-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.jvir.2023.11.026_bib30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/cncr.34028","article-title":"Association of high-dose radiotherapy with improved survival in patients with newly diagnosed low-grade gliomas","volume":"128","author":"Liu","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2023.11.026_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-022-04206-1","article-title":"Dose-response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy","volume":"161","author":"Kim","year":"2023","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.jvir.2023.11.026_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2967\/jnumed.113.136044","article-title":"Tumor-absorbed dose predicts progression-free survival following (131)i-tositumomab radioimmunotherapy","volume":"55","author":"Dewaraja","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bib33","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"2002"},{"key":"10.1016\/j.jvir.2023.11.026_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.11.026_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/cancers15030645","article-title":"For hepatocellular carcinoma treated with yttrium-90 microspheres, dose volumetrics on post-treatment bremsstrahlung SPECT\/CT predict clinical outcomes","volume":"15","author":"Taswell","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2023.11.026_bib36","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2023.11.026_bib37","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2023.11.026_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2018.01.116","article-title":"Prospective trial using internal pair-production positron emission tomography to establish the yttrium-90 radioembolization dose required for response of hepatocellular carcinoma","volume":"101","author":"Chan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2023.11.026_bib39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.1994.436","article-title":"Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study","volume":"70","author":"Lau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2023.11.026_bib40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","article-title":"Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations","volume":"51","author":"Strigari","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bibe1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.11.026_bibe2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","article-title":"Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations","volume":"51","author":"Strigari","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2023.11.026_bibe3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.1994.436","article-title":"Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study","volume":"70","author":"Lau","year":"1994","journal-title":"Br J Cancer"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T08:34:24Z","timestamp":1713861264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1051044324000265"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2023.11.026","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Treated by Yttrium-90 Resin Microsphere Radioembolization: A Retrospective Analysis Using Technetium-99m Macroaggregated Albumin SPECT\/CT and Planning Software","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2023.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}